Helix announces election of new board member

12-Jan-2005

Helix BioPharma announced that, at its Annual General Meeting, Mr. Jack Kay, President and Chief Operating Officer of Apotex Inc., was elected to its board of directors. Mr. Kay has more than 40 years of experience in the pharmaceutical industry, primarily in senior executive positions. In addition to serving as the President and Chief Operating Officer of Apotex, Mr. Kay is the director of two publicly traded pharmaceutical companies, as well as the Chairman of the Board of the International Schizophrenic Society and the Chairman of the Board of Directors of the Humber River Regional Hospital in Toronto.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances